Real‐world treatment and prognostic factors for survival in ALK+ non‐small cell lung cancer (NSCLC) patients with brain metastases in China

Abstract Background To explore the efficacy and prognostic factors of different treatment modalities on anaplastic lymphoma kinase (ALK)+ non‐small cell lung cancer (NSCLC) patients with brain metastases (BMs). Methods A total of 86 patients were enrolled into the study. They were divided into two c...

Full description

Bibliographic Details
Main Authors: Na Li, Mingying Xie, Zichao Zhou, Jiamin Sheng, Xiaoqing Yu, Yun Fan
Format: Article
Language:English
Published: Wiley 2023-01-01
Series:Thoracic Cancer
Subjects:
Online Access:https://doi.org/10.1111/1759-7714.14739